A mixed model allows the incorporation of both fixed and random variables within a statistical analysis. This enables efficient inferences and more information to be gained from the data. The application of mixed models is an increasingly popular way of analysing medical data, particularly in the pharmaceutical industry. There have been many recent advances in mixed modelling, particularly regarding the software and applications. This new edition of a groundbreaking text discusses the latest developments, from updated SAS techniques to the increasingly wide range of applications. Presents an...

With increasing rates of pollution to both land and aquatic environments, regulations for the quality of our waters are necessarily becoming more stringent. In the light of recent epidemiological studies new criteria are being established for the safety of our recreational waters. In order for such criteria to be developed an established statistical framework needs to be in place. Statistical Framework for Recreational Water Quality Criteria and Monitoring offers a practical guide to the statistical methods used for assessing health effects and monitoring and modelling water quality. Both...

A valuable new edition of the trusted, practical guide to managing data in clinical trials

Regardless of size, type, or complexity, accurate results for any clinical trial are ultimately determined by the quality of the collected data. Management of Data in Clinical Trials, Second Edition explores data management and trial organization as the keys to developing an accurate and reliable clinical trial. With a focus on the traditional aspects of data collection as well as recent advances in technology, this new edition provides a complete and accessible guide to the management...

Studies in bioequivalence are the commonly accepted method to demonstrate therapeutic equivalence between two medicinal products. Savings in time and cost are substantial when using bioequivalence as an established surrogate marker of therapeutic equivalence. For this reason the design, performance and evaluation of bioequivalence studies have received major attention from academia, the pharmaceutical industry and health authorities.

Bioequivalence Studies in Drug Development focuses on the planning, conducting, analysing and reporting of bioequivalence studies, covering all aspects...

Statistical Estimation of Epidemiological Risk provides coverage of the most important epidemiological indices, and includes recent developments in the field. A useful reference source for biostatisticians and epidemiologists working in disease prevention, as the chapters are self-contained and feature numerous real examples. It has been written at a level suitable for public health professionals with a limited knowledge of statistics.

Other key features include:

• Provides comprehensive coverage of the key epidemiological indices.
• Includes coverage of various...

Disease mapping involves the analysis of geo-referenced disease incidence data and has many applications, for example within resource allocation, cluster alarm analysis, and ecological studies. There is a real need amongst public health workers for simpler and more efficient tools for the analysis of geo-referenced disease incidence data. Bayesian and multilevel methods provide the required efficiency, and with the emergence of software packages - such as WinBUGS and MLwiN - are now easy to implement in practice.

• Provides an introduction to Bayesian and multilevel modelling in...

Dose-finding experiments define the safe dosage of a drug in development, in terms of the quantity given to a patient. Statistical methods play a crucial role in identifying optimal dosage. Used appropriately, these methods provide reliable results and reduce trial duration and costs. In practice, however, dose-finding is often done poorly, with widely used conventional methods frequently being unreliable, leading to inaccurate results. However, there have been many advances in recent years, with new statistical techniques being developed and it is important that these new techniques are...

Selection bias can, and does, occur, even in randomized clinical trials. Steps need to be taken in order to ensure that this does not compromise the integrity of clinical trials; hence "Selection Bias and Covariate Imbalances in Randomized Clinical Trials" offers a comprehensive treatment of the subject and the methodology involved. This book:

• Provides an overview of the hierarchy of study designs, and justifies the position of randomised trials at the top of this hierarchy.
• Discusses the strengths and defects of randomisation, and provides real evidence to justify concern...

Assessing Weight-of-Evidence for DNA Profiles is an excellent introductory text to the use of statistical analysis for assessing DNA evidence. It offers practical guidance to forensic scientists with little dependence on mathematical ability as the book includes background information on statistics - including likelihood ratios - population genetics, and courtroom issues.

The author, who is highly experienced in this field, has illustrated the book throughout with his own experiences as well as providing a theoretical underpinning to the subject. It is an ideal choice for forensic...

The need to understand, interpret and analyse competing risk data is key to many areas of science, particularly medical research. There is a real need for a book that presents an overview of methodology used in the interpretation and analysis of competing risks, with a focus on practical applications to medical problems, and incorporating modern techniques. This book fills that need by presenting the most up-to-date methodology, in a way that can be readily understood, and applied, by the practitioner.